You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Details for New Drug Application (NDA): 207466

✉ Email this page to a colleague

« Back to Dashboard

NDA 207466 describes METAXALONE, which is a drug marketed by Actavis Labs Fl Inc, Amneal Pharms, Lannett Co Inc, Mountain, Novast Labs, Primus Pharms, Rising, Sandoz, and Sciegen Pharms Inc, and is included in nine NDAs. It is available from thirty suppliers. There is one patent protecting this drug. Additional details are available on the METAXALONE profile page.

The generic ingredient in METAXALONE is metaxalone. There are twenty drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the metaxalone profile page.

Summary for 207466

Tradename:	METAXALONE
Applicant:	Sciegen Pharms Inc
Ingredient:	metaxalone
Patents:	0

Pharmacology for NDA: 207466

Physiological Effect	Centrally-mediated Muscle Relaxation

Suppliers and Packaging for NDA: 207466

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
METAXALONE	metaxalone	TABLET;ORAL	207466	ANDA	Misemer Pharmaceuticals, Inc.	0276-0508	0276-0508-10	100 TABLET in 1 BOTTLE (0276-0508-10)
METAXALONE	metaxalone	TABLET;ORAL	207466	ANDA	Major Pharmaceuticals	0904-6831	0904-6831-04	30 BLISTER PACK in 1 CARTON (0904-6831-04) / 1 TABLET in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	800MG
Approval Date:	Aug 31, 2017	TE:	AB	RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	400MG
Approval Date:	Mar 13, 2020	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.